輸液管路套裝及配件市場（依產品類型、材料類型、最終用戶、通路及應用分類）－2025-2032年全球預測

預計到 2032 年，靜脈輸液管路及配件市場規模將達到 24.3 億美元，複合年成長率為 5.79%。

主要市場統計數據
基準年 2024	15.5億美元
預計年份：2025年	16.4億美元
預測年份：2032年	24.3億美元
複合年成長率 (%)	5.79%

本文全面介紹了臨床需求、材料創新和製造品質如何影響靜脈輸液管路及配件的研發。

輸液管路及其配件在現代醫療保健服務中發揮著至關重要的作用，它們是輸送重要液體、藥物、血液製品和營養物質的物理通道。這些產品兼具相對簡單的機械設計和嚴苛的臨床性能，其研發體現了材料科學、人體工學、感染預防和生產品質系統等方面的持續互動。隨著醫療保健機構不斷追求更高的安全性和操作效率，對輸液管路及其配件的要求也隨之提升，包括增強生物相容性、抗扭結性、精確的流量控制以及與先進輸液泵和封閉式輸液裝置的兼容性。

從急診病房到門診診所再到家庭醫療保健，在各種醫療環境中，臨床醫生和採購團隊都在優先考慮能夠降低感染風險、減少用藥錯誤並簡化治療流程的醫療器材。因此，製造商正在增加對產品組合中各項創新技術的投入，例如專為兒科和低流量應用設計的微孔導管、便於同時進行治療的多腔導管以及旨在提高手術靈活性的延長管。同時，材料選擇和供應鏈的連續性是決定產品性能和成本競爭力的關鍵因素。因此，對於那些希望產品系列與不斷發展的醫療標準和業務需求保持一致的相關人員而言，全面了解臨床需求、監管要求和供應商能力至關重要。

深入分析臨床、監管和技術因素的融合，這些因素正在重塑輸液裝置生態系統的供應鏈和產品優先順序。

輸液管路及配件市場正受到臨床、監管和技術等多方面因素的共同影響而改變。在臨床方面，門診病人治療和家庭輸液的普及正在重塑設備易用性要求，並推動對簡化連接器和可由非臨床醫護人員安全操作的輸液系統的需求。同時，人們對導管相關感染和用藥錯誤的日益關注，加速了封閉式系統、無針連接器以及減少操作的設計方案的普及。這些臨床壓力促使供應商優先考慮那些能夠支援易用性、清晰標籤和醫療機構間標準化的設計方案。

在監管方面，各司法管轄區正加強對生物相容性和材料可追溯性的審查，迫使製造商加強文件記錄、檢驗和供應商審核。技術進步也在重塑產品性能。積層製造和精密擠出技術提高了微孔和多腔管材的公差，而分析技術和數位化工具則實現了從生產到分銷的更完善的品質監控。同時，採購團隊正透過籌資策略多元化來應對成本壓力，包括近岸外包和多源採購，並改變供應商關係和合約動態。總而言之，這些變化為那些能夠將卓越的監管能力、材料專業知識和以用戶為中心的設計理念相結合，以滿足臨床醫生和患者不斷變化的需求的公司創造了一個更加複雜但也充滿機會的市場。

從策略觀點2025 年關稅調整將如何改變輸液管製造商和採購商的採購、材料選擇和供應鏈韌性。

美國計劃於2025年調整關稅政策，將對包括輸液管路套裝及其配件在內的醫療耗材的成本和供應動態產生重大影響。進口原料和成品組件的關稅可能會改變到岸成本，迫使製造商和醫療負責人重新評估籌資策略。為此，許多製造商可能會加快供應商多元化，尋求替代聚合物來源或增加對國內委託製造製造商的依賴。此類調整可能會產生與資質認證、監管檢驗和物流重組相關的過渡成本，並可能促使企業進行長期投資，以建立本地產能，從而降低關稅波動帶來的風險。

此外，關稅也將影響產品設計決策。採購主導的成本控制可能會促使材料替代，轉向兼顧成本和臨床性能的聚合物；而對品質的重視則需要進行嚴格的測試，以確保替代材料不會影響安全性。供應鏈轉型也將影響庫存策略。醫療機構和經銷商可能會選擇持有更多緩衝庫存或協商更長期的供應協議，以降低中斷風險。此外，在低關稅地區擁有垂直整合營運或策略夥伴關係關係的製造商可能會享有相對優勢，迫使競爭對手尋求整合，並圍繞服務、品質和監管可靠性打造差異化的提案主張。關稅變化的累積影響將取決於相關人員調整採購政策、檢驗替代材料以及重組生產佈局的速度。

詳細的細分洞察，揭示產品類型、材料、最終用戶、分銷管道和臨床應用如何影響採購行為和創新重點。

細分市場分析揭示了因產品類型、材料配置、終端用戶環境、分銷管道和臨床應用而異的細微需求模式，這些因素共同影響相關人員的優先事項和競爭動態。按產品類型分類，行業關注的焦點包括：用於提高手術靈活性的延長管、針對低流量和兒科給藥最佳化的微孔導管、可實現同步治療的多腔導管以及用於常規輸注的標準導管。聚乙烯和聚氨酯的特點是柔韌性和拉伸性能優異，而聚氯乙烯 (PVC) 則具有成本效益高的透明度和易於加工的特點，矽膠則滿足對柔軟性和生物相容性要求極高的特殊需求。產品設計和材料選擇之間的相互作用通常決定了其臨床適用性和製造複雜性。

終端使用者——包括門診診所、普通診所、家庭醫療保健機構和醫院——各自需要獨特的解決方案，不同的偏好會影響採購和產品開發。在診所中，一般診所優先考慮易用性和成本效益，而專科診所則要求產品能夠相容於各種精細的治療方案。醫院分為公立和私立兩類，各自的採購機制和標準化壓力各不相同。市場動態正在進一步改變市場進入和採購行為。雖然醫院藥局仍然是主要的採購管道，但線上管道（製造商直銷網站和第三方電商平台）正在擴大採購的便利性和覆蓋範圍。零售藥局的分銷涵蓋連鎖店和獨立藥局，批發商採用全方位服務和專業模式來滿足各種庫存和物流需求。最後，在輸血、藥物輸送、輸液和腸外營養等應用領域，血漿、血小板、紅血球、大劑量投藥與控釋、持續輸注與間歇輸注等細分類別對產品性能和監管提出了嚴格的要求，並影響著特定的產品屬性和臨床培訓考量。了解這些細分之間的相互關係，可以讓產品經理和採購負責人調整產品，優先考慮研發投資，並制定符合臨床工作流程和監管要求的分銷策略。

從關鍵區域觀點出發，闡述美洲、歐洲、中東和非洲以及亞太地區如何各自影響採購優先事項、監管重點和供應商策略。

區域動態對輸液管路及配件的需求促進因素、法規要求和供應鏈結構有顯著影響。在美洲，大型醫院系統的整合以及強勁的家庭醫療保健業務推動了對標準化散裝產品和麵向消費者的家庭輸液解決方案的需求。該地區的法規環境著重於供應商合格和上市後監管，而報銷機制和分銷網路則決定了採購窗口和合約條款。相較之下，歐洲、中東和非洲的管理體制、公共採購模式和臨床引進週期呈現複雜的格局。該地區的一些市場優先考慮永續性和減少一次性用品的使用，而另一些市場則更注重成本控制和在地化生產獎勵。

亞太地區醫院重建和門診病人設施的需求正快速成長，因此催生了既有成熟的跨國供應商，也有新興的本土製造商。監管協調和本土製造能力的提升推動了國內產量的成長，進而影響全球供應鏈和價格動態。在每個地區內部，臨床醫生培訓、感染控制通訊協定和基礎設施成熟度的差異都會影響產品需求。因此，區域策略必須在符合全球品質標準的同時，兼顧區域特定的產品組合、通路策略和供應商關係，才能有效滿足不同的臨床和採購需求。

在該領域中觀察到的高影響力企業策略強調創新、卓越製造、夥伴關係以及不斷發展的分銷管道，以確立市場領導地位。

為了保持競爭力，靜脈輸液管及配件產業的主要企業致力於產品差異化、卓越營運和策略夥伴關係。創新重點在於改進材料科學，以提高生物相容性和抗扭結性；開發可降低感染風險的連接系統；以及採用模組化設計，簡化臨床醫生的工作流程。同時，他們強調透過檢驗的品質系統、供應商可追溯性和嚴格的變更控制流程來確保生產的穩健性，從而滿足監管要求，並加快迭代改進產品的上市速度。

與契約製造、醫療設備新興企業和臨床研究中心建立策略聯盟十分普遍，這使得大型企業能夠在無需承擔全部內部研發成本的情況下加速產能擴張。分銷策略也在不斷演變，一些公司加強了直接面向醫生的分銷管道或數位化商務能力，而另一些公司則利用批發商網路和與醫院藥房的合作來覆蓋不同的終端用戶群體。在財務方面，企業正採取諸如定向收購利基技術供應商、投資本地製造能力以及與聚合物製造商簽訂長期供應協議等措施，以確保原料供應並降低關稅和物流風險。最終，兼具臨床洞察力、嚴格的品管和靈活的分銷模式的公司，將更有能力滿足複雜的客戶需求並適應監管變化。

製造商和醫療保健負責人應採取指南，加強材料策略，實現生產多元化，並在產品價值與臨床安全性之間取得平衡。

行業領導者應採取積極主動的策略，將產品創新、供應鏈韌性和商業性可行性與不斷變化的臨床和監管要求相結合。針對聚乙烯、聚氨酯、聚氯乙烯和矽膠替代品製定嚴格的認證途徑，並加快生物相容性測試，可以在需要進行替代時減少時間和風險。其次，實現製造地多元化，並在多個地區建立有效的契約製造關係，可以降低關稅和物流中斷的風險，同時縮短醫院和診所的前置作業時間。第三，投資於連接器標準化和封閉式系統可以解決臨床醫生對安全的擔憂，並在以感染預防為核心標準的競標過程中脫穎而出。

此外，企業應透過建構D2B商務能力和加強第三方電商夥伴關係，提升數位參與度和通路彈性，同時透過服務等級協議和庫存管理解決方案最佳化與醫院藥局、零售和批發商的關係。從組織層級來看，將監管資訊納入產品開發週期並持續進行上市後監測，有助於簡化核准流程並支持相關聲明的論點。最後，提出以金額為準導向的提案，例如減少不利事件、簡化工作流程或將設備屬性與總醫療成本掛鉤，將引起尋求永續臨床和經濟效益的採購團隊的共鳴。綜合運用這些措施，將有助於掌握醫療保健格局變化、監管日益嚴格以及供應鏈重組所帶來的機會。

我們透明的調查方法結合了臨床和採購的初步訪談、專家文獻研究和供應鏈分析，以提供可靠、可操作的見解。

本研究採用混合方法，整合了主要相關人員訪談、技術文獻綜述和供應鏈圖譜分析，以全面了解靜脈輸液管路及配件市場現狀。主要研究包括對臨床醫生、採購負責人、法規專家和生產主管進行結構化訪談，以獲取關於臨床需求、採購促進因素和營運限制的第一手資訊。此外，還分析了法規指導文件、生物相容性和無菌標準以及生產最佳實踐，從而基於當前的合規框架提供相關見解。

我們的供應鏈分析繪製了上游聚合物採購、擠出產能和下游分銷管道的分佈圖，以識別潛在的瓶頸和應對策略。在資料檢驗，我們將訪談主題與專有的品質保證文件和生產流程基準進行了交叉比對。在條件允許的情況下，我們採用了三角測量法來協調不同的觀點，確保結論的穩健性。調查方法的局限性包括監管解讀的區域差異以及某些合約製造外包協議的特殊性，這些協議可能無法反映具體的成本結構。這種綜合調查方法使我們能夠將臨床需求、材料科學考量和營運實際情況連結起來，從而為策略決策提供可靠的依據。

總結全文，重點闡述了臨床需求、材料創新和供應鏈韌性之間的相互作用，以及它們如何決定輸液設備市場的競爭成功。

總之，輸液管路套裝及配件仍然是醫療保健服務中至關重要且充滿活力的領域，其發展受到臨床需求訊號、材料創新、不斷變化的法規以及供應鏈架構轉變的影響。該領域的特點是產品創新不斷漸進，以應對臨床醫生對安全性的擔憂以及醫院外持續護理的擴展。同時，調整關稅政策和發展區域製造能力等宏觀層面的影響正迫使相關人員重新評估籌資策略、實現供應商關係多元化並加快替代材料的認證。

展望未來，那些將臨床洞察融入產品開發、確保生產製造的靈活性和韌性，並闡明與安全性和工作流程效率緊密相關的清晰價值提案的機構，將更有能力克服不確定性，並從不斷變化的醫療模式中獲益。貫穿整個價值鏈（包括製造商、經銷商、臨床醫生和監管機構）的協作至關重要，它能確保產品創新轉化為可衡量的臨床改善和營運效益。最終，對品質、法規遵循和以客戶為中心的設計的高度重視，將決定哪些參與企業能夠在這個不斷變化的環境中取得成功。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

• 抗菌塗層輸液管的廣泛應用有助於預防導管相關血流感染疾病
• 擴大無針連接器和閥門系統的使用，以減少醫院內的針刺傷。
• 整合與即時劑量監測和分析管路套件相容的智慧輸液泵
• 改用一次性無菌靜脈輸液器，以最大限度地減少交叉感染並簡化工作流程。
• 開發抗扭結、低顆粒物的管材，以提高病人安全性並減少阻塞。
• 預連接式靜脈輸液管路套裝正逐漸成為首選，因為它能縮短設定時間，並最大限度地降低輸液過程中的污染風險。
• 加大的兒科靜脈輸液管套裝採用微孔設計，可提高兒科輸液的準確性
• 為解決環境永續性問題，環保型可生物分解輸液管組件的出現引起了人們的注意。
• 用於靜脈輸液管的標準化接頭確保了不同輸液幫浦品牌之間的兼容性

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 輸液管路套裝及配件市場（依產品類型分類）

• 擴張
• 微型鑽孔
• 多流明
• 標準

9. 依材料類型分類的靜脈輸液管路及配件市場

• 聚乙烯
• 聚氨酯
• PVC
• 矽

第10章 依最終用戶分類的輸液管路套裝及配件市場

• 門診治療
• 診所
  • 一般的
  • 專業
• 家庭醫療保健
• 醫院
  • 私人的
  • 公共

第11章 依通路分類的靜脈輸液管路及配件市場

• 醫院藥房
• 線上
  • 廠商直銷網站
  • 第三方電子商務
• 零售藥房
  • 鏈
  • 獨立
• 批發的
  • 全方位服務
  • 專業

第12章 按應用分類的輸液管路套裝及配件市場

• 輸血
  • 電漿
  • 血小板
  • 紅血球
• 給藥途徑
  • 快速靜脈注射
  • 控制
• 注射
  • 連續的
  • 間歇性的
• 靜脈營養

第13章 輸液管路套裝及配件市場（依地區分類）

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第14章 輸液管路套裝及配件市場（依組別分類）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第15章 各國輸液管路及配件市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第16章 競爭格局

• 2024年市佔率分析
• FPNV定位矩陣，2024
• 競爭分析
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Terumo Corporation
  • ICU Medical, Inc.
  • Smiths Group plc
  • Cardinal Health, Inc.
  • Teleflex Incorporated
  • Nipro Corporation

The IV Tubing Sets & Accessories Market is projected to grow by USD 2.43 billion at a CAGR of 5.79% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 1.55 billion
Estimated Year [2025]	USD 1.64 billion
Forecast Year [2032]	USD 2.43 billion
CAGR (%)	5.79%

Comprehensive introduction outlining how clinical demands, material innovation, and manufacturing quality converge to shape intravenous tubing sets and accessory development

Intravenous tubing sets and accessories occupy a foundational role in contemporary healthcare delivery, serving as the physical conduit for life-sustaining fluids, drugs, blood products, and nutrition. These products combine relatively simple mechanical design with stringent clinical performance expectations, and their development reflects a continuous interplay between material science, user ergonomics, infection prevention, and manufacturing quality systems. As healthcare providers pursue higher standards of safety and operational efficiency, the expectations placed on tubing sets and ancillary devices have evolved to include improved biocompatibility, kink resistance, precise flow control, and compatibility with advanced infusion pumps and closed-system transfer devices.

Across care settings, from acute hospital wards to ambulatory clinics and home healthcare environments, clinicians and procurement teams increasingly prioritize devices that reduce infection risk, minimize medication errors, and simplify care pathways. Consequently, manufacturers are investing in incremental innovation across product families, including microbore lines engineered for pediatric and low-flow applications, multi-lumen configurations that facilitate simultaneous therapies, and extension sets designed for procedural flexibility. At the same time, material selection and supply chain continuity are central determinants of product performance and cost competitiveness. Therefore, an integrated view of clinical needs, regulatory requirements, and supplier capabilities is essential for stakeholders seeking to align product portfolios with evolving standards of care and operational imperatives.

Detailed analysis of converging clinical, regulatory, and technological forces that are redefining supply chains and product priorities across infusion device ecosystems

The landscape for intravenous tubing sets and accessories is undergoing transformative shifts driven by converging forces across clinical practice, regulation, and technology. Clinically, the drive toward outpatient care and home-based infusions is reshaping device usability requirements, increasing demand for simplified connectors and infusion systems that non-clinical caregivers can manage safely. Simultaneously, heightened awareness of catheter-associated infections and medication administration errors has accelerated adoption of closed systems, needleless connectors, and designs that limit manipulation. These clinical pressures are pushing suppliers to prioritize ease of use, clear labeling, and designs that support standardization across care sites.

On the regulatory front, jurisdictions are tightening scrutiny on biocompatibility and material traceability, which compels manufacturers to enhance documentation, validation, and supplier audits. Technological advances are also reshaping product capabilities: additive manufacturing and precision extrusion techniques are improving tolerances for microbore and multi-lumen tubing, while analytics and digital tools enable better quality monitoring across production and distribution. In parallel, procurement teams are responding to cost pressures by diversifying sourcing strategies, including nearshoring and multi-sourcing, which alters supplier relationships and contract dynamics. Taken together, these shifts are producing a more complex, but also more opportunity-rich, marketplace for organizations that can combine regulatory excellence, materials expertise, and user-centered design to meet the changing needs of clinicians and patients.

Strategic perspective on how 2025 tariff adjustments will reshape sourcing, material selection, and supply chain resilience for infusion tubing manufacturers and purchasers

United States tariff policy changes slated for 2025 introduce a material variable into the cost and supply dynamics of medical consumables, including intravenous tubing sets and accessories. Tariffs on imported raw materials or finished components can alter landed costs, prompting manufacturers and healthcare purchasers to reassess sourcing strategies. In response, many manufacturers may accelerate supplier diversification, seek alternative polymer sources, or increase reliance on domestic contract manufacturers. These adjustments are likely to involve transitional costs related to qualification, regulatory revalidation, and logistical reconfiguration, and they may also incentivize longer-term investments in local capacity building to reduce exposure to tariff volatility.

Moreover, tariffs can influence product design decisions. Procurement-driven cost containment may steer material substitution efforts toward polymers that balance cost and clinical performance, while preservational commitments to quality will require robust testing to ensure substitutions do not compromise safety. Transitioning supply chains also affects inventory strategies: healthcare organizations and distributors may choose to hold higher buffer stocks or negotiate longer-term supply agreements to mitigate disruption risk. In addition, manufacturers with vertically integrated operations or strategic partnerships in low-tariff jurisdictions may gain relative advantage, forcing competitors to pursue consolidation or differentiated value propositions centered on service, quality, and regulatory reliability. Ultimately, the cumulative impact of tariff changes will be mediated by how swiftly stakeholders adapt procurement policies, validate alternative materials, and realign manufacturing footprints.

In-depth segmentation insights revealing how product types, materials, end users, distribution routes, and clinical applications collectively drive procurement behavior and innovation priorities

Segmentation analysis reveals nuanced demand patterns that vary according to product type, material composition, end-user environment, channels of distribution, and clinical application, each shaping stakeholder priorities and competitive dynamics. Based on product type, industry attention is distributed across extension sets for procedural flexibility, microbore tubing optimized for low-flow and pediatric administration, multi-lumen formats that enable concurrent therapies, and standard tubing employed in routine infusions. Material selection plays a central role in performance and acceptance, with polyethylene and polyurethane offering distinct flexibility and tensile properties, PVC providing cost-efficient clarity and processing familiarity, and silicone serving specialty needs where softness and biocompatibility are paramount. The interplay between product design and material choice often dictates clinical suitability as well as manufacturing complexity.

End users exhibit differentiated preferences that influence procurement and product development, with ambulatory care sites, clinics, home healthcare settings, and hospitals each demanding tailored solutions. Within clinics, general practice settings prioritize ease of use and cost-effectiveness while specialty clinics require compatibility with nuanced therapeutic protocols. Hospitals present a bifurcation between private and public institutions, each with distinct procurement mechanisms and standardization pressures. Channel dynamics further modulate market access and purchasing behavior: hospital pharmacies continue to be a primary procurement node, while online channels-both direct manufacturer websites and third-party e-commerce platforms-are expanding convenience and reach. Retail pharmacy distribution spans chain and independent outlets, and wholesalers operate through full-service and specialized models to meet different inventory and logistics needs. Finally, applications such as blood transfusion, drug administration, infusion, and parenteral nutrition impose rigorous performance and regulatory requirements, with subcategories like plasma, platelets, red blood cells, bolus versus controlled administration, and continuous versus intermittent infusion driving specific product attributes and clinical training considerations. Understanding how these segmentation dimensions interconnect allows product managers and procurement leaders to tailor offerings, prioritize development investments, and design distribution strategies that align with clinical workflows and regulatory demands.

Key regional perspectives describing how the Americas, Europe Middle East & Africa, and Asia-Pacific each shape procurement priorities, regulatory focus, and supplier strategies

Regional dynamics exert a profound influence on demand drivers, regulatory requirements, and supply chain architecture for intravenous tubing sets and accessories. In the Americas, a high degree of consolidation among large hospital systems coexists with a robust home healthcare segment, creating demand for both standardized bulk products and consumer-friendly home infusion solutions. This region's regulatory environment emphasizes supplier qualification and post-market surveillance, while reimbursement structures and distribution networks shape procurement windows and contract terms. In contrast, Europe, Middle East & Africa presents a complex mosaic of regulatory regimes, varying public procurement models, and divergent clinical adoption cycles; certain markets within the region prioritize sustainability and single-use reduction initiatives, whereas others emphasize cost containment and local manufacturing incentives.

Asia-Pacific displays rapid growth in demand across hospital expansions and outpatient facilities, accompanied by a mix of established multinational suppliers and emergent local manufacturers. Regulatory harmonization efforts and rising local manufacturing capability are encouraging greater domestic production, which in turn affects global supply chains and pricing dynamics. Across all regions, differences in clinician training, infection control protocols, and infrastructure maturity shape product requirements-from advanced multi-lumen lines in tertiary centers to robust, easy-to-use sets for community and home care. Consequently, regional strategies must balance global quality standards with localized product configurations, channel approaches, and supplier relationships to meet heterogeneous clinical and procurement needs effectively.

High-impact corporate strategies observed across the sector highlighting innovation, manufacturing excellence, partnerships, and distribution channel evolution that define market leadership

Leading companies in the intravenous tubing and accessories sector are pursuing a mix of product differentiation, operational excellence, and strategic partnerships to sustain competitiveness. Innovation is concentrated on material science improvements that deliver better biocompatibility and kink resistance, the development of connector systems that reduce infection risk, and modular designs that ease clinician workflows. Concurrently, firms emphasize manufacturing robustness through validated quality systems, supplier traceability, and rigorous change control processes to meet regulatory expectations and reduce time-to-market for iterative improvements.

Strategic collaborations with contract manufacturers, medical device startups, and clinical research centers are common, enabling larger firms to accelerate capability expansion without bearing the full cost of in-house R&D. Distribution strategies are also evolving: some companies are strengthening direct-to-provider channels and digital commerce capabilities, while others leverage wholesaler networks and hospital pharmacy partnerships to maintain coverage across diverse end-user segments. Financially, corporate actions such as targeted acquisitions of niche technology providers, investments in localized manufacturing capacity, and long-term supply agreements with polymer producers are being used to secure raw material access and mitigate tariff or logistics risk. Ultimately, companies that combine clinical insight, disciplined quality management, and agile distribution models are better positioned to meet complex customer requirements and respond to regulatory change.

Actionable recommendations for manufacturers and healthcare purchasers to strengthen materials strategy, diversify manufacturing, and align product value with clinical safety imperatives

Industry leaders should adopt a proactive agenda that aligns product innovation, supply chain resilience, and commercial execution with evolving clinical and regulatory requirements. First, prioritizing materials strategy will pay dividends: rigorous qualification pathways for polyethylene, polyurethane, PVC, and silicone alternatives, coupled with accelerated biocompatibility testing, can reduce time and risk when substitutions are required. Second, diversifying manufacturing footprints and establishing validated contract manufacturing relationships in multiple geographies will mitigate tariff and logistical disruption risks while enabling more responsive lead times for hospitals and clinics. Third, investing in connector standardization and closed systems will address clinician safety concerns and can be a differentiator in tender processes where infection prevention is a central criterion.

Additionally, companies should enhance digital engagement and channel flexibility by building direct-to-provider commerce capabilities and strengthening third-party e-commerce partnerships, while ensuring that hospital pharmacy, retail, and wholesale relationships remain optimized through service-level agreements and inventory management solutions. From an organizational perspective, embedding regulatory intelligence into product development cycles and maintaining proactive post-market surveillance will smooth approval pathways and support claims substantiation. Finally, leading with value-based propositions-linking device attributes to reduced adverse events, simplified workflows, or total cost of care-will resonate with procurement teams seeking sustainable clinical and economic outcomes. Taken together, these actions will position organizations to capture opportunities created by shifting care settings, regulatory tightening, and supply chain realignment.

Transparent research methodology combining primary clinical and procurement interviews with technical literature review and supply chain mapping to ensure robust, actionable findings

This research synthesis is built on a mixed-methods approach that integrates primary stakeholder engagement, technical literature review, and supply chain mapping to produce a comprehensive view of the intravenous tubing sets and accessories landscape. Primary research involved structured interviews with clinicians, procurement leaders, regulatory specialists, and manufacturing executives to capture firsthand insights into clinical needs, purchasing drivers, and operational constraints. These qualitative inputs were complemented by an analysis of regulatory guidance documents, standards for biocompatibility and sterilization, and manufacturing best practices to ground findings in current compliance frameworks.

Supply chain analysis mapped upstream polymer sourcing, extruder capabilities, and downstream distribution channels to identify potential bottlenecks and resilience strategies. Data validation included cross-referencing interview-derived themes with proprietary quality assurance documentation and manufacturing process benchmarks. Where possible, triangulation techniques were used to reconcile divergent perspectives and ensure robustness of conclusions. Limitations of the methodology include variability in regional regulatory interpretations and the proprietary nature of some contract manufacturing agreements, which can constrain visibility into certain cost structures. Nevertheless, the combined methodological approach provides a reliable basis for strategic decision-making by linking clinical imperatives, material science considerations, and operational realities.

Conclusive synthesis emphasizing the interplay of clinical needs, material innovation, and supply chain resilience as determinants of competitive success in infusion device markets

In conclusion, intravenous tubing sets and accessories remain a critical yet dynamic category within healthcare delivery, shaped by clinical demand signals, material innovation, regulatory evolution, and shifting supply chain architectures. The sector is characterized by incremental product innovation that responds to clinician safety concerns and the expanding continuum of care beyond hospital walls. At the same time, macro-level influences such as tariff policy adjustments and regional manufacturing capacity development are prompting stakeholders to rethink sourcing strategies, diversify supplier relationships, and accelerate qualification of alternative materials.

Moving forward, organizations that integrate clinical insights into product development, secure resilient and flexible manufacturing arrangements, and articulate clear value propositions tied to safety and workflow efficiency will be best positioned to navigate uncertainty and capture the benefits of shifting care paradigms. Collaboration across the value chain-including manufacturers, distributors, clinicians, and regulatory bodies-will be essential to ensure that product innovation translates into measurable clinical improvements and operational advantages. Ultimately, a disciplined focus on quality, regulatory readiness, and customer-centric design will determine which players succeed in this evolving environment.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Increasing adoption of antimicrobial-coated IV tubing sets to prevent catheter related bloodstream infections
• 5.2. Growing utilization of needleless connectors and valve systems for reducing needlestick injuries in hospitals
• 5.3. Integration of smart infusion pumps compatible with tubing sets for real-time dosage monitoring and analytics
• 5.4. Shift towards single-use sterile IV administration sets to minimize cross-contamination and simplify workflow
• 5.5. Development of kink-resistant and low-particle tubing materials to enhance patient safety and reduce blockages
• 5.6. Rising preference for preattached IV tubing sets to decrease setup time and minimize contamination risk during administration
• 5.7. Expansion of specialized pediatric IV tubing sets with microbore designs to improve dosing accuracy in children
• 5.8. Emergence of eco-friendly biodegradable IV tubing components to address environmental sustainability concerns
• 5.9. Adoption of standardized connectors for IV tubing sets to ensure compatibility across different infusion pump brands

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IV Tubing Sets & Accessories Market, by Product Type

• 8.1. Extension
• 8.2. Microbore
• 8.3. Multi-Lumen
• 8.4. Standard

9. IV Tubing Sets & Accessories Market, by Material Type

• 9.1. Polyethylene
• 9.2. Polyurethane
• 9.3. PVC
• 9.4. Silicone

10. IV Tubing Sets & Accessories Market, by End User

• 10.1. Ambulatory Care
• 10.2. Clinics
  • 10.2.1. General
  • 10.2.2. Specialty
• 10.3. Home Healthcare
• 10.4. Hospitals
  • 10.4.1. Private
  • 10.4.2. Public

11. IV Tubing Sets & Accessories Market, by Channel Of Distribution

• 11.1. Hospital Pharmacy
• 11.2. Online
  • 11.2.1. Direct Manufacturer Website
  • 11.2.2. Third-Party E-Commerce
• 11.3. Retail Pharmacy
  • 11.3.1. Chain
  • 11.3.2. Independent
• 11.4. Wholesale
  • 11.4.1. Full-Service
  • 11.4.2. Specialized

12. IV Tubing Sets & Accessories Market, by Application

• 12.1. Blood Transfusion
  • 12.1.1. Plasma
  • 12.1.2. Platelets
  • 12.1.3. Red Blood Cells
• 12.2. Drug Administration
  • 12.2.1. Bolus
  • 12.2.2. Controlled
• 12.3. Infusion
  • 12.3.1. Continuous
  • 12.3.2. Intermittent
• 12.4. Parenteral Nutrition

13. IV Tubing Sets & Accessories Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. IV Tubing Sets & Accessories Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. IV Tubing Sets & Accessories Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Becton, Dickinson and Company
  • 16.3.2. Baxter International Inc.
  • 16.3.3. B. Braun Melsungen AG
  • 16.3.4. Fresenius Kabi AG
  • 16.3.5. Terumo Corporation
  • 16.3.6. ICU Medical, Inc.
  • 16.3.7. Smiths Group plc
  • 16.3.8. Cardinal Health, Inc.
  • 16.3.9. Teleflex Incorporated
  • 16.3.10. Nipro Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. IV TUBING SETS & ACCESSORIES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. IV TUBING SETS & ACCESSORIES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. IV TUBING SETS & ACCESSORIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY EXTENSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MICROBORE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MULTI-LUMEN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY GENERAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DIRECT MANUFACTURER WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHAIN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY FULL-SERVICE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SPECIALIZED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PLATELETS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BOLUS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTROLLED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL IV TUBING SETS & ACCESSORIES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 255. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 256. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 257. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 258. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 259. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 260. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 261. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 262. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 263. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
• TABLE 264. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
• TABLE 265. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 266. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 267. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2024 (USD MILLION)
• TABLE 268. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2025-2032 (USD MILLION)
• TABLE 269. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 270. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
• TABLE 271. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
• TABLE 272. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
• TABLE 273. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2024 (USD MILLION)
• TABLE 274. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2025-2032 (USD MILLION)
• TABLE 275. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 276. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 277. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2018-2024 (USD MILLION)
• TABLE 278. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY BLOOD TRANSFUSION, 2025-2032 (USD MILLION)
• TABLE 279. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 280. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY DRUG ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 281. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2018-2024 (USD MILLION)
• TABLE 282. AMERICAS IV TUBING SETS & ACCESSORIES MARKET SIZE, BY INFUSION, 2025-2032 (USD MILLION)
• TABLE 283. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 284. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 285. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 286. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 287. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 288. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 289. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 290. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 291. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
• TABLE 292. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
• TABLE 293. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 294. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 295. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2018-2024 (USD MILLION)
• TABLE 296. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY CHANNEL OF DISTRIBUTION, 2025-2032 (USD MILLION)
• TABLE 297. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 298. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY ONLINE, 2025-2032 (USD MILLION)
• TABLE 299. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
• TABLE 300. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
• TABLE 301. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2018-2024 (USD MILLION)
• TABLE 302. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SIZE, BY WHOLESALE, 2025-2032 (USD MILLION)
• TABLE 303. NORTH AMERICA IV TUBING SETS & ACCESSORIES MARKET SI